Global Hospital, Parel, Announced the launch Of the robot-assisted Heart Surgery programme

India Pharma Outlook Team | Saturday, 01 July 2023

 India Pharma Outlook Team

Global Hospital in Parel, Mumbai, has announced the commencement of its new robot-assisted heart surgery programme, which aims to reduce recovery time and problems for patients undergoing delicate heart surgery. Dr. Chandrashekhar Kulkarni, senior consultant CVTS and lead Heart Transplant Surgeon at Global Hospital, Parel, is in charge of the programme. He has vast experience performing minimally invasive heart surgery. According to Dr. Chandrashekhar Kulkarni, senior consultant CVTS and lead Heart Transplant Surgeon at The Global Hospital, Parel, the hospital's robot-assisted heart surgery programme is outfitted with the most recent Da Vinci Xi robotic surgical equipment.

Using this technology, surgeons may execute difficult heart procedures with higher precision and accuracy than traditional open-heart procedures. Smaller incisions, less blood loss, and faster healing times benefit patients. Robotic procedures are also less intrusive, resulting in fewer complications and less pain for patients. Furthermore, the employment of robotic technology aids in the reduction of infection risk and the shortening of hospital stays. Overall, he believes that robotic-assisted heart surgery is a game changer in the field of heart surgery. “The surgeon operates the robotic arms using specialized instruments from a console in the operating room during the procedure.

The advanced technology of the robot allows for greater precision and accuracy, resulting in better outcomes for patients undergoing delicate heart surgeries like cardiac bypass surgery. CEO of Global Hospitals, Mumbai Dr Vivek Talaulikar said the launch of the robot-assisted heart surgery program at Global Hospital in Parel, Mumbai is a significant achievement for the hospital. This is because it aligns with their commitment to providing cutting-edge medical technology and innovative procedures that lead to better outcomes for patients.

© 2024 India Pharma Outlook. All Rights Reserved.